REHOVOT, Israel, July 28, 2021 /PRNewswire/ -- Evogene Ltd.
(NASDAQ: EVGN) (TASE: EVGN), a leading computational biology
company aiming to revolutionize life-science product development
across several market segments, announces today that it will
release its financial results for the second quarter of 2021 on
Wednesday, August 11th, 2021. Ms.
Sarit Firon Evogene's incoming Chairperson of the Board, will join
the conference call to discuss her vision for Evogene.
On the day of the announcement, the Company's management will
host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call,
please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609
internationally. Access to the call will also be available via live
webcast through the Company's website at www.evogene.com.
A replay of the conference call will be available approximately
two hours following the completion of the call. To access the
replay, please dial +1-888-326-9310 toll free from the United States, or +972-3-925-5901
internationally. The replay will be accessible through August 13th, 2021, and an archive of the webcast
will be available on the webcast link for the following twelve
months.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN, TASE: EVGN) is a leading
computational biology company focused on revolutionizing product
discovery and development in multiple life-science based
industries, including human health and agriculture, through the use
of our broadly applicable Computational Predictive Biology (CPB)
platform. The CPB platform, incorporating a deep understanding
of biology leveraged through the power of Big Data and Artificial
Intelligence, has been designed to computationally discover and
uniquely guide the development of life-science products based on
microbes, small molecules and genetic elements. Utilizing the
CPB platform, Evogene and its subsidiaries are now advancing
product pipelines for human microbiome-based therapeutics through
Biomica Ltd., medical cannabis through Canonic Ltd.,
ag-biologicals through Lavie Bio Ltd., ag-chemicals through
AgPlenus Ltd., and ag-solutions for castor oil
production through Casterra Ltd. For more information, please
visit www.evogene.com.
Evogene Investor Contact:
Aviva Banczewski / Rivka Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1900
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
View original
content:https://www.prnewswire.com/news-releases/evogene-financial-results-and-earnings-announcement-schedule-for-the-second-quarter-of-2021-301343032.html
SOURCE Evogene